Award
National Cancer Institute 5R61CA278402-03
Intersectional genetics-based biosensors for dormant cancer cells
Recipient
Icahn School of Medicine at Mount Sinai
Award Amount
$213,638.00
Ceiling
$213,638.00
Awarded
September 05, 2025
Identifier
5R61CA278402-03
Award for developing biosensors targeting dormant cancer cells using intersectional genetics and synthetic biology, funded by the National Cancer Institute for a project duration from 2023 to 2027.
Description
Project to devise a dormant cancer cell biosensor using intersectional genetics and synthetic biology. The project aims to develop biosensors for dormant cancer cells using intersectional genetics and synthetic biology. It involves advanced genomic activity profiling and genetic sensor development. The project team is based at the Icahn School of Medicine at Mount Sinai, NY. The project addresses the poorly understood mechanisms of cancer cell dormancy to develop targeted therapies to prevent metastasis.